FIFTH THIRD BANCORP
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 35527
CINCINNATI, OH
Position in REGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$26,972,862
+$15,066,768 QoQ
Shares Held
34,910
+126.3% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 82.12260097393298.ToString("F0")%
Shared 0.ToString("F0")%
None 17.877399026067028.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $165,893,632 across 150 Biotechnology names. REGN ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
88,499 | $39,518,343 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
34,910 | $26,972,862 | |
| 3 | VCEL |
Vericel Corp
|
256,688 | $8,257,652 | |
| 4 | LCTX |
Lineage Cell Therapeutics, Inc.
|
4,600,000 | $7,268,000 | |
| 5 | TECH |
BIO-TECHNE Corp
|
136,521 | $7,134,587 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
63,800 | $5,370,046 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
68,128 | $4,403,112 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
51,238 | $4,267,613 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,972,862 | 34,910 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $11,906,094 | 15,425 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $6,782,663 | 12,063 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $5,320,350 | 10,134 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $4,877,862 | 7,691 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $6,156,668 | 8,643 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $10,928,691 | 10,396 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $8,674,150 | 8,253 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $8,057,966 | 8,372 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $7,563,833 | 8,612 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $7,138,355 | 8,674 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $6,223,274 | 8,661 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $6,970,226 | 8,483 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $6,334,682 | 8,780 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $6,015,901 | 8,733 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $5,048,841 | 8,541 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $8,953,744 | 12,820 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $8,308,908 | 13,157 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $7,540,542 | 12,460 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $4,734,743 | 8,477 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $9,416,432 | 19,902 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $11,286,415 | 23,362 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $14,737,328 | 26,327 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $15,974,171 | 25,614 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $8,741,367 | 17,902 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||